The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Mr Ian Jacobson
    Born in March 1960
    Individual (12 offsprings)
    Person with significant control
    2020-12-01 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 2
    Ichiyen, Christopher Scott Noboru
    Company Director born in April 1966
    Individual (1 offspring)
    Officer
    2020-12-01 ~ now
    OF - Director → CIF 0
  • 3
    Fraser-pye, Graham Julian
    Company Director born in March 1968
    Individual (17 offsprings)
    Officer
    2020-08-25 ~ now
    OF - Director → CIF 0
    Graham Julian Fraser-pye
    Born in March 1968
    Individual (17 offsprings)
    Person with significant control
    2020-08-25 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 4
    Reinhardt, Christopher Peter
    Company Director born in June 1963
    Individual (1 offspring)
    Officer
    2020-12-01 ~ now
    OF - Director → CIF 0
parent relation
Company in focus

STARK PHARMACEUTICALS LIMITED

Standard Industrial Classification
21200 - Manufacture Of Pharmaceutical Preparations
Brief company account
Debtors
7,437 GBP2022-12-31
2,151 GBP2021-12-31
Cash at bank and in hand
1,769 GBP2022-12-31
8,204 GBP2021-12-31
Current Assets
9,206 GBP2022-12-31
10,355 GBP2021-12-31
Creditors
Current, Amounts falling due within one year
-1,076,420 GBP2022-12-31
-336,661 GBP2021-12-31
Net Current Assets/Liabilities
-1,067,214 GBP2022-12-31
-326,306 GBP2021-12-31
Equity
Called up share capital
100 GBP2022-12-31
100 GBP2021-12-31
Retained earnings (accumulated losses)
-1,067,314 GBP2022-12-31
-326,406 GBP2021-12-31
Equity
-1,067,214 GBP2022-12-31
-326,306 GBP2021-12-31
Average Number of Employees
02022-01-01 ~ 2022-12-31
02020-08-25 ~ 2021-12-31
Trade Debtors/Trade Receivables
Current
0 GBP2022-12-31
65 GBP2021-12-31
Other Debtors
Current
7,437 GBP2022-12-31
2,086 GBP2021-12-31
Debtors
Current, Amounts falling due within one year
7,437 GBP2022-12-31
2,151 GBP2021-12-31
Trade Creditors/Trade Payables
Current
668,008 GBP2022-12-31
0 GBP2021-12-31
Other Creditors
Current
405,412 GBP2022-12-31
334,161 GBP2021-12-31
Accrued Liabilities/Deferred Income
Current
3,000 GBP2022-12-31
2,500 GBP2021-12-31
Creditors
Current
1,076,420 GBP2022-12-31
336,661 GBP2021-12-31
Equity
Called up share capital
100 GBP2022-12-31
100 GBP2021-12-31

  • STARK PHARMACEUTICALS LIMITED
    Info
    Registered number 12837365
    Cannon Place, 78 Cannon Street, London EC4N 6AF
    Private Limited Company incorporated on 2020-08-25 (4 years 10 months). The company status is Active.
    The last date of confirmation statement was made at 2024-08-24
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.